All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

11

Reset

11 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • INS1009Treprostinil PalmitilPhase 37 trials

    Insmed Incorporated · Interstitial Lung Disease, Pulmonary Hypertension, Pulmonary Arterial Hypertension

  • IKT-001Phase 32 trials

    Inhibikase Therapeutics · Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension (PAH)

  • RalinepagAPD811Phase 32 trials

    United Therapeutics · PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension

  • SeralutinibPhase 32 trials

    Gossamer Bio USA, Inc. · Pulmonary Arterial Hypertension

  • HS235Phase 22 trials

    35Pharma Inc., a GSK company · Pulmonary Arterial Hypertension, Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction

  • NS-863Phase 22 trials

    NS Pharma, Inc. · Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD), Pulmonary Arterial Hypertension

  • APL-9796Phase 21 trial

    Apollo Therapeutics Ltd · Pulmonary Arterial Hypertension

  • DIAG723Phase 21 trial

    Diagonal Therapeutics, Inc. · Hereditary Hemorrhagic Telangiectasia, Pulmonary Arterial Hypertension

  • PF-07868489Phase 21 trial

    Pfizer · Pulmonary Arterial Hypertension

  • REGN13335Phase 21 trial

    Regeneron · Pulmonary Arterial Hypertension (PAH)

  • ROC-101Phase 21 trial

    AllRock Bio, Inc. · Pulmonary Arterial Hypertension (PAH), Pulmonary Hypertension, Interstitial Lung Disease

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.